Projects
Heart Outcomes Prevention Evaluation - 3 Study (HOPE-3)
Project Description
An RCT to evaluate the safety and efficacy of rosuvastatin and candesartan / hydrochlorothiazide and their combinations in middle aged people who are at an intermediate risk for vascular events.
Project Duration
2009 - Ongoing
Project Lead
Dr. Prem Pais, Dr. Denis Xavier
Authors
Dr Denis Xavier
Project Status
completed
Project Type
Source of Funding: Population Health Research Institute, Canadian Institutes of Health Research, AstraZeneca